US79957L1008
US79957L1008
Sanara MedTech Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 322.22M EUR | 216.87M EUR | 157.46M EUR | 208.91M EUR |
Enterprise Value | 355.14M EUR | 249.98M EUR | 192.23M EUR | 240.52M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 64.94x | -- | -- | -- |
Price to Sales | 2.93x | 1.97x | 1.46x | 2.62x |
Price to Book | 40.59x | 27.3x | 22.4x | 35.18x |
EV/Revenue | 3.23x | 2.28x | 1.79x | 3.02x |
EV/EBITDA | 27.86x | 21.31x | 14.65x | 23.28x |
Price to FCF (P/FCF) | 56.54x | 48.15x | 47x | 35.66x |
EV/FCF | 62.32x | 55.5x | 57.38x | 41.05x |
FCF Yield | 1.77% | 2.08% | 2.13% | 2.8% |